SOFHOUR Finance SOFHOUR Finance
IPO desk
Sign in
Report a bugTell us what went wrong. We read every report.

What kind of problem?

We also send the page link and your browser name, to help us fix it.

Healthcare · NIFTY 500

Granules India Limited

NSEGRANULES BSE532482 ISININE101D01020 SeriesEQ Listed on NSE · BSE

₹840.50 +41.25 (+5.16%) Updated 12 Nov, 8:49 pm IST

Price, daily close+40.86% in a year

Today

Open
₹802.00
Prev close
₹799.25
Day high
₹847.00
Day low
₹797.00
Volume
58.77 L
Value traded
₹483.64 Cr
Upper circuit
₹959.10
Lower circuit
₹639.40
52W high
₹923.65
52W low
₹529.85
1 month
-1.89%
6 months
+5.83%
52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹22,927 Cr
P/E (TTM)29.42
P/B3.49
Book value / share₹240.73
EPS (TTM)₹28.57
ROE10.9%
Dividend yield0.21%
Dividend (12m)₹1.75 / share
Net margin (TTM)12.1%
Operating margin21.6%
Debt / equity0.09
Current ratio2.60
EV / EBITDA16.71
Sales growth (YoY qtr)+20.28%
Profit growth (YoY qtr)+39.23%
Sales CAGR 3Y+5.95%
Profit CAGR 3Y+4.82%
Shares27.28 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

1,156126
Dec 23
1,176139
Mar 24
1,180135
Jun 24
96797.2
Sep 24
1,138118
Dec 24
1,197152
Mar 25
1,210110
Jun 25
1,297131
Sep 25
1,388150
Dec 25
1,471202
Mar 26
1,477180
Jun 26
1,560182
Sep 26

Revenue · QoQ (vs last quarter)

—+1.7%+0.3%-18%+18%+5.3%+1.1%+7.2%+7.0%+6.0%+0.4%+5.6%

Revenue · YoY (vs a year ago)

————-1.5%+1.8%+2.6%+34%+22%+23%+22%+20%

Net profit · QoQ (vs last quarter)

—+11%-3.1%-28%+21%+29%-27%+18%+15%+34%-11%+1.0%

Net profit · YoY (vs a year ago)

————-6.4%+9.4%-18%+34%+28%+33%+63%+39%
RevenueNet profitLine = trend
5.18
Dec 23
5.35
Mar 24
5.55
Jun 24
4.01
Sep 24
4.85
Dec 24
6.27
Mar 25
4.64
Jun 25
5.38
Sep 25
6.19
Dec 25
8.23
Mar 26
7.12
Jun 26
7.03
Sep 26

EPS (₹) · YoY (vs a year ago)

————-6.4%+17%-16%+34%+28%+31%+53%+31%
EPS (₹)Line = trend

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

2,2793840.0
FY19
2,5995530.0
FY20
3,238855549
FY21
3,765722413
FY22
4,512914517
FY23
4,506856426
FY24
4,482976502
FY25
5,3661,175595
FY26

Revenue · YoY (vs a year ago)

—+14%+25%+16%+20%-0.1%-0.5%+20%

Net profit · YoY (vs a year ago)

———-25%+25%-18%+18%+19%
RevenueOperating profitNet profitLine = trend

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

2,8351,059292
Mar 23
3,2261,223381
Mar 24
3,7161,286466
Mar 25
5,0851,338880
Mar 26
6,567619945
Sep 26

Shareholders' equity · YoY (vs a year ago)

—+14%+15%+37%—
Shareholders' equityBorrowingsCashLine = trend

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

332-380190
FY22
739-191-440
FY23
439-3607.7
FY24
867-691-92.5
FY25
793-773379
FY26

Operations · YoY (vs a year ago)

—+122%-41%+97%-8.5%
OperationsInvestingFinancingLine = trend

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

38.9%Jun 24
38.9%Sep 24
38.9%Dec 24
38.8%Mar 25
38.8%Jun 25
38.8%Sep 25
38.8%Dec 25
38.0%Feb 26
38.0%Mar 26
38.0%Jun 26
37.4%Sep 26
37.4%Sep 26
Promoter & groupPublic

Latest (30 Sep 2026)

37.4%promoter
Promoter & group
37.39%
Public (FIIs, mutual funds, retail…)
62.61%
Promoter change, last quarter
0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

  • Dividend - Rs 1.75 Per Share
  • Dividend - Rs 1.50 Per Share
  • Annual General Meeting/Dividend - Rs 1.50 Per Share
  • Dividend - Rs 1.50 Per Share
  • Annual General Meeting
  • Buy Back
  • Annual General Meeting/Dividend - Rs 0.75 Per Share
  • Interim Dividend - Rs 0.25 Per Share

Board meetings

  • the financial results for the period ended September 30, 2026
  • GRANULES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Finan…
  • GRANULES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 21-Jul-2026 to inter-alia consider and approve the Unaudited Finan…
  • the financial results for the period ended Jun 30, 2026
  • the Quarterly Audited Financial results of the Company for the period ended March 2026 and Dividend.

Filings with NSE

  • Analysts/Institutional Investor Meet/Con. Call Updates
  • General Updates
  • Analysts/Institutional Investor Meet/Con. Call Updates
  • Analysts/Institutional Investor Meet/Con. Call Updates
  • Monitoring Agency Report
  • Analysts/Institutional Investor Meet/Con. Call Updates
  • Press Release

About

About Granules India Limited

Granules India Limited is an Indian pharmaceutical manufacturing company headquartered in Hyderabad, Telangana, India. The company is involved in the manufacture and sale of finished dosage forms (FDs), pharmaceutical formulation intermediates (PFIs), active pharmaceutical ingredients (APIs).

From Wikipedia (CC BY-SA 4.0).

Company details

Company name
Granules India Limited
NSE symbol
GRANULES
BSE scrip code
532482
ISIN
INE101D01020
Listed on
NSE, BSE
Series
EQ (normal equity)
Listed on NSE since
20 Jun 2005
Face value
₹1 per share
Market lot
1 share
Shares issued
27.28 crore
Index
NIFTY 500
Sector (NSE)
Healthcare
Industry
Pharmaceuticals: Other
Managing director / CEO
Krishna Prasad Chigurupati
Chair
Krishna Prasad Chigurupati
Headquarters
Hyderabad, Telangana, India
Registered address
15th Floor, Granules Tower,Botanical Garden Road, Kondapur, Hyderabad – 500084, Telangana, India.
Founded
1984
Employees
6,523
Financial year
April to March
Results basis
Consolidated

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.